申请人:KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
公开号:US11530221B2
公开(公告)日:2022-12-20
Disclosed are a compound selected from novel pyrimido[4,5-d]pyrimidin-2-one derivative compounds having excellent anti-proliferative activity against cancer cells, pharmaceutically acceptable salts thereof, hydrates thereof and stereoisomers thereof, a method for preparing the compound, a pharmaceutical composition for preventing, alleviating or treating cancer metastasis and proliferative diseases containing the compound as an active ingredient, and an anticancer composition against cancer cells, containing the compound as an active ingredient. The compounds of this invention exhibit most excellent selective inhibitory activity against LCK and anti-proliferative activity against cancer cells, thus being useful for inhibiting cancer cells, and for preventing or treating cancer metastasis and proliferative diseases.
本发明公开了一种选自具有优异抗癌细胞增殖活性的新型嘧啶并[4,5-d]嘧啶-2-酮衍生物化合物、其药学上可接受的盐、其水合物和其立体异构体的化合物、制备该化合物的方法、含有该化合物作为活性成分的用于预防、缓解或治疗癌症转移和增殖性疾病的药物组合物,以及含有该化合物作为活性成分的抗癌组合物。本发明的化合物对 LCK 具有最优异的选择性抑制活性,对癌细胞具有抗增殖活性,因此可用于抑制癌细胞,预防或治疗癌症转移和增殖性疾病。